References

Aneja S Benzodiazepines for acute management of seizures. Indian J Pediatr. 2012; 79:(3)381-2

Ashrafi MR, Khosroshahi N, Karimi P Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol. 2010; 14:(5)434-8

Bridgwater: Class Professional Publishing; 2013

Gathwala G, Goel M, Singh J, Mittal K Intravenous diazepam, midazolam and lorazepam in acute seizure control. Indian J Pediatr. 2012; 79:(3)327-32

Holsti M, Dudley N, Schunk J Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010; 164:(8)747-53

Javadzadeh M, Sheibani K, Hashemieh M, Saneifard H Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial. Iran J Pediatr. 2012; 22:(1)1-8

Lammers R, Byrwa M, Fales W Root causes of errors in a simulated prehospital pediatric emergency. Acad Emerg Med. 2012; 19:(1)37-47

London: The Stationery Office;

Scott RC, Besag FM, Meville BG Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999; 353:(9153)623-6

Sofou K, Kristjánsdóttir R, Papachatzakis NE, Ahmadzadeh A, Uvebrant P Management of prolonged seizures and status epilepticus in childhood: a systematic review. J Child Neurol. 2009; 24:(8)918-26

Talukdar B, Chakrabarty B Efficacy of buccal midazolam compared to intravenous diazepam in controllong convulsion in children: a randomised controlled trial. Brain Dev. 2009; 31:(10)744-9

Thakker A, Shanbag P A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. J Neurol. 2013; 260:(2)470-4

Tonekaboni SH, Shamsabadi FM, Anvari SS, Mazrooei A, Ghofrani M A comparison of buccal midazolam and intravenous diazepam for the acute treatment of seizures in children. Iran J Pediatr. 2012; 22:(3)303-8

Ulgey A, Aksu R, Bicer C Nasal and buccal treatment of midazolam in epileptic seizures in pediatrics. Clin Med Insights Pediatr. 2012; 6:51-60

Warden CR, Frederick C Midazolam and diazepam for pediatric seizures in the prehospital setting. Prehosp Emerg Care. 2006; 10:(4)463-7

Pre-hospital paediatric seizures: midazolam versus diazepam

02 October 2014
Volume 6 · Issue 10

Abstract

This literature review aims to scope the current evidence for use of diazepam and midazolam for managing seizures in children, with particular focus on pre-hospital management. Many emergency departments now use buccal midazolam as first-line treatment for managing paediatric seizures, while ambulance services continue to use diazepam via the rectal (PR) or intravenous (IV) route.

This review concludes that the evidence for the continued use of diazepam by ambulance services should be reconsidered if we are to provide the best standard of care for our paediatric patients—and move our treatment in line with best practice, and what is considered the norm in a hospital setting.

Current UK ambulance service clinical practice guidelines (Association of Ambulance Chief Executives, 2013) include rectal (PR) and intravenous (IV) diazepam for use by paramedics to terminate seizures. The guidelines also advocate use of patient's own buccal midazolam (BM), but this is not currently carried out by UK paramedics (Association of Ambulance Chief Executives, 2013). Many patients with seizures will only require supportive care and limited intervention from the pre-hospital clinicians (Warden and Frederick, 2006). However, those patients who have complex, prolonged seizures or are found to be in status epilepticus, require drug therapy to terminate the seizure and prevent neurological insult (Warden and Frederick, 2006; Association of Ambulance Chief Executives, 2013). Before the guidelines were updated in 2013, paramedics were able to administer two doses of PR diazepam to account for difficulty in establishing IV access and facilitating prompt termination of seizures. Since the update in 2013, the second dose of PR diazepam was removed and emphasis was placed on early IV access and administration of IV diazepam. Diazepam is quickly able to cross the blood-brain barrier, but dosing may last just 30 minutes, resulting in the need for further drug administration. With repeat dosing, diazepam can accumulate and persist, sometimes causing unexpected side effects, including central nervous system (CNS) depression and impaired respiratory function (Aneja, 2012). Seizures are a common neurological emergency encountered in children and are associated with significant morbidity and mortality (Aneja, 2012). A primary goal of treatment is prompt seizure termination, and good evidence exists for the use of midazolam via the intranasal (IN) and buccal routes for the termination of paediatric seizures (Warden and Frederick, 2006; Aneja, 2012). The IN and buccal routes have proven effective, safe and are more socially acceptable than current PR diazepam (Scott et al, 1999).

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed